US Stock MarketDetailed Quotes
ZVSAW ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM)
- 0.070
- 0.0000.00%
Close Dec 20 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.070Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.10052wk High0.00P/B0Float Cap0.05752wk Low--Dividend TTM0Shs Float0.210Historical High--Div YieldTTM0.00%Amplitude0.057Historical Low--Avg Price1Lot Size
About ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) Company
ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.
Company Profile
SymbolZVSAW
Company NameZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM)
CEOMr. Stephen C. Glover
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.zyversa.com
Company Executives
- Name
- Position
- Salary
- Stephen C. Glover
- Chairman of the Board and Chief Executive Officer
- --
- Nicholas A. LaBella,Jr
- Chief Scientific Officer
- --
- Karen A. Cashmere
- Chief Commercial Officer
- --
- Peter Wolfe
- Chief Financial Officer
- --
- Daniel J. O’Connor, J.D.
- Director
- --
- Dr. Min-Chul Park, Pd.D
- Director
- --
- Robert G. Finizio
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg